Pacira BioSciences Inc
PCRX
ISIN null / Valor 12338490
Pacira BioSciences Inc
UMushroom community rating:
About company
Pacira BioSciences Inc is a pharmaceutical company that specializes in developing innovative drug delivery technologies for pain management. Their flagship product, ZILRETTA®, is the first and only approved treatment for osteoarthritis knee pain utilizing extended-release microsphere technology. In addition, the company also offers the iovera° system, an FDA-approved handheld cryoanalgesia device that delivers precise doses of cold temperature to targeted nerves, providing immediate pain relief that can last for up to three months. Pacira BioSciences Inc's proprietary multivesicular liposome (pMVL) technology allows for the encapsulation of drugs without altering their molecular structure, ensuring effective and long-lasting pain management solutions for patients.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
978 M
Market cap (USD)
728,254
Daily traded volume (Shares)
19.4 / 18.895
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
